Rates of metformin use in stage 3B chronic kidney disease rose after FDA label change Journal Article

   

Authors:	Huang, A.; Wu, X.; Orloff, J.; Min, J. Y.; Flory, J.
Article Title:	Rates of metformin use in stage 3B chronic kidney disease rose after FDA label change
Journal Title:	Journal of General Internal Medicine
Volume:	36
Issue:	10
ISSN:	0884-8734
Publisher:	Springer
Date Published:	2021-10-01
Start Page:	3261
End Page:	3263
Language:	English
PMCID:	PMC8481432
DOI:	10.1007/s11606-020-06380-2
PROVIDER:	scopus
PUBMED:	33409883
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099014179&doi=10.1007%2fs11606-020-06380-2&partnerID=40&md5=d5d3272775d749deafbae5a690e71311
Notes:	Article -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/188925